No 1 Date of announcement 2025/12/22 Time of announcement 18:08:51 Subject Announcement of Board of Directors’ resolution on the appointment of the Company’s Acting spokesperson and Financial officer. Date of events 2025/12/22 To which item it meets paragraph 8 Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.),...Read More
No 1 Date of announcement 2025/12/15 Time of announcement 18:06:16 Subject The Company announces the information about the investor conference of Q4, 2025. Date of events 2025/12/23 To which item it meets paragraph 12 Date of institutional investor conference:2025/12/23 Time of institutional investor conference:15:00 (GMT+8) Location of institutional investor conference: Online investor conference Outline of...Read More
發布日期：2025-12-09 原始連結：https://pharmaboardroom.com/interviews/yenchen-huang-head-of-investment-vp-diamond-biofund-taiwan/ PHARMA BOARDROOM｜2025.12.09 We describe ourselves as “entrepreneurs behind entrepreneurs” – not merely passive capital providers but active partners throughout the journey. Yenchen Huang – Head of Investment & VP, Diamond Biofund, Taiwan How does dual scientific and investment expertise shape investment decisions at Diamond Biofund? Diamond Biofund’s investment...Read More
December 8, 2025 PRNewswire NES ZIONA, Israel, Dec. 8, 2025 /PRNewswire/ — EyeYon Medical Ltd., a global leader in ophthalmic innovation, today announced that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to initiate a U.S. clinical study of EndoArt®, the world’s first synthetic endothelial layer for the treatment of chronic corneal edema. EndoArt®...Read More
No 1 Date of announcement 2025/12/05 Time of announcement 17:14:17 Subject Announcement for the changes in the numbers of shares and their fair value held in the Company’s portfolio as well as the Company’s BVPS and cash balance. Date of events 2025/12/05 To which item it meets paragraph 51 Date of occurrence of the event:2025/12/05...Read More
No 2 Date of announcement 2025/11/10 Time of announcement 19:01:39 Subject Announcement for the Board of Directors’ Resolutionon the appointment and removal of the Company’s Chief Internal Auditor Date of events 2025/11/10 To which item it meets paragraph 8 Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.),...Read More
No 4 Date of announcement 2025/11/10 Time of announcement 19:02:23 Subject The Board of Directors approved the Company’s donation. Date of events 2025/11/10 To which item it meets paragraph 43 Date of occurrence of the event:2025/11/10 Reason for the donation: Donation to the Taiwan Bio-development Foundation, designated for the” Academic seminars ”, to continuously support...Read More
No 3 Date of announcement 2025/11/10 Time of announcement 19:02:00 Subject Announcement for the Board of Directors’ Resolution to lift the non-competition restrictions on the Company’s Managers. Date of events 2025/11/10 To which item it meets paragraph 21 Date of the board of directors resolution:2025/11/10 Name and title of the managerial officer with permission to...Read More
No 1 Date of announcement 2025/11/10 Time of announcement 19:01:19 Subject The Company’s 2025Q3 financial statements have been approved by the Board of Directors Date of events 2025/11/10 To which item it meets paragraph 31 Date of submission to the board of directors or approval by the board of directors:2025/11/10 Date of approval by the...Read More
No 1 Date of announcement 2025/11/07 Time of announcement 17:36:21 Subject Announcement for the changes in the numbers of shares and their fair value held in the Company’s portfolio as well as the Company’s BVPS and cash balance. Date of events 2025/11/07 To which item it meets paragraph 51 Date of occurrence of the event:2025/11/07...Read More
